Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity.
about
Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.SRC-3Delta4 mediates the interaction of EGFR with FAK to promote cell migrationRegulation of HER2 oncogene transcription by a multifunctional coactivator/corepressor complexThe role and regulation of the nuclear receptor co-activator AIB1 in breast cancer.MACROD2 overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers.Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial contentA PAK-activated linker for EGFR and FAKRole of the nuclear receptor coactivator AIB1-Delta4 splice variant in the control of gene transcription.Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.Minireview: steroid receptor coactivator-3: a multifarious coregulator in mammary gland metastasis.SRC-3/AIB1: transcriptional coactivator in oncogenesis.The role of AIB1 in breast cancerIdentification and characterization of PNRC splicing variants.Taiman acts as a coactivator of Yorkie in the Hippo pathway to promote tissue growth and intestinal regeneration.Steroid receptor coactivator (SRC) family: masters of systems biology.A proteomic microarray approach for exploring ligand-initiated nuclear hormone receptor pharmacology, receptor selectivity, and heterodimer functionality.AIB1 is a predictive factor for tamoxifen response in premenopausal women.
P2860
Q24796687-E6F19FD2-D260-4772-AC63-50461E55361DQ27852024-FF8449B9-E929-4C02-8229-5D7C45BDF4A5Q28273310-986717C7-F317-48CD-991B-C4E595AFDA48Q33701396-7638F640-793B-4A5C-807F-7FF45798B1F5Q34286419-E115E574-06EE-43E5-BC06-7D7D3A68FFD8Q34708926-FE8C025B-0777-4FA4-A75B-62FA9F535A50Q34712100-06702D57-4F8E-4B82-924D-6DCF9A06345DQ34846990-B59BB39E-1E1F-4E36-A4E2-B966263861B0Q35128269-7B56664A-3443-4F9C-B65A-0611A9B44D50Q35157919-B44D3742-852E-4AAC-B812-0780539771FCQ35558470-A39D07F2-4D88-41C0-B7F4-8C0EDE36F04BQ36422215-DB3E50BD-B0B1-41A2-A9AF-4777AFC44C18Q36423878-E80108DE-8986-41B4-A8A4-117C881877D2Q36817286-E6B603E3-573C-4089-A879-5A043D939FCAQ36883174-F1BB4785-C92B-4ECB-83D1-90633B4FE9D6Q37801217-C6D924D4-30EB-4B08-AB0E-AEA02556E495Q45197336-96EDC63D-195E-4E0A-9504-323BE80267DBQ45921492-6371D5B1-7EB1-4C01-B93E-5064C2EB4B63
P2860
Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Impact of the nuclear receptor ...... different intrinsic activity.
@en
type
label
Impact of the nuclear receptor ...... different intrinsic activity.
@en
prefLabel
Impact of the nuclear receptor ...... different intrinsic activity.
@en
P2860
P356
P1433
P1476
Impact of the nuclear receptor ...... h different intrinsic activity
@en
P2093
Anna Tate Riegel
Ronald Reiter
P2860
P2888
P304
P356
10.1038/SJ.ONC.1207202
P407
P577
2004-01-01T00:00:00Z
P5875
P6179
1003077367